Interestingly, metabolic protein expression of CD34+ cells from adult and pediatric AML differ in multiple pathways including TCA and FAO, suggesting differentiated treatment when metabolic targets should be considered (unpublished data). Here, CD34 is linked to acute myeloid leukemia.